Renaissance Technologies’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.6M Sell
335,517
-14,600
-4% -$2.24M 0.08% 303
2025
Q4
$48M Sell
350,117
-23,750
-6% -$3.07M 0.07% 309
2025
Q3
$45.4M Sell
373,867
-13,600
-4% -$1.47M 0.06% 383
2025
Q2
$41.5M Sell
387,467
-16,900
-4% -$1.69M 0.06% 408
2025
Q1
$37.5M Buy
404,367
+22,500
+6% +$2.18M 0.06% 412
2024
Q4
$41.1M Sell
381,867
-9,400
-2% -$1.14M 0.06% 386
2024
Q3
$49.2M Sell
391,267
-6,900
-2% -$868K 0.07% 325
2024
Q2
$43.2M Sell
398,167
-8,800
-2% -$858K 0.07% 332
2024
Q1
$38.5M Sell
406,967
-7,500
-2% -$710K 0.06% 396
2023
Q4
$38.3M Sell
414,467
-13,200
-3% -$1.01M 0.06% 373
2023
Q3
$27.4M Sell
427,667
-13,400
-3% -$858K 0.05% 444
2023
Q2
$27.3M Sell
441,067
-13,800
-3% -$818K 0.04% 530
2023
Q1
$26.4M Sell
454,867
-11,900
-3% -$684K 0.04% 584
2022
Q4
$27.8M Sell
466,767
-36,220
-7% -$2.2M 0.04% 565
2022
Q3
$31.9M Sell
502,987
-42,500
-8% -$2.95M 0.05% 466
2022
Q2
$38.1M Sell
545,487
-5,600
-1% -$392K 0.05% 443
2022
Q1
$38.7M Sell
551,087
-15,400
-3% -$1.04M 0.05% 437
2021
Q4
$38.5M Sell
566,487
-23,600
-4% -$1.63M 0.05% 412
2021
Q3
$41.3M Sell
590,087
-13,100
-2% -$953K 0.05% 376
2021
Q2
$42.2M Sell
603,187
-18,400
-3% -$1.34M 0.05% 387
2021
Q1
$48.4M Sell
621,587
-47,500
-7% -$3.36M 0.06% 360
2020
Q4
$44.4M Sell
669,087
-8,913
-1% -$587K 0.05% 393
2020
Q3
$42.2M Sell
678,000
-21,000
-3% -$1.31M 0.04% 435
2020
Q2
$44.3M Buy
699,000
+33,200
+5% +$2.23M 0.04% 471
2020
Q1
$47.8M Sell
665,800
-1,400
-0.2% -$111K 0.05% 405
2019
Q4
$57.7M Buy
667,200
+9,600
+1% +$802K 0.04% 470
2019
Q3
$53.8M Buy
657,600
+9,300
+1% +$770K 0.05% 476
2019
Q2
$52.6M Buy
648,300
+1,500
+0.2% +$116K 0.05% 472
2019
Q1
$49.1M Buy
646,800
+44,100
+7% +$3.5M 0.04% 521
2018
Q4
$47.3M Buy
602,700
+16,300
+3% +$1.28M 0.05% 448
2018
Q3
$44.2M Buy
586,400
+27,200
+5% +$2M 0.05% 489
2018
Q2
$39.4M Buy
559,200
+29,200
+6% +$1.91M 0.04% 549
2018
Q1
$31.6M Sell
530,000
-2,000
-0.4% -$123K 0.03% 666
2017
Q4
$32.4M Buy
532,000
+36,400
+7% +$2.32M 0.04% 644
2017
Q3
$31M Buy
495,600
+73,100
+17% +$4.71M 0.04% 646
2017
Q2
$29.6M Buy
422,500
+63,074
+18% +$4.5M 0.04% 628
2017
Q1
$25.6M Buy
359,426
+30,526
+9% +$2.26M 0.04% 656
2016
Q4
$24.9M Buy
328,900
+28,600
+10% +$1.98M 0.04% 648
2016
Q3
$19.8M Buy
300,300
+4,000
+1% +$260K 0.04% 710
2016
Q2
$19.2M Sell
296,300
-9,100
-3% -$578K 0.04% 709
2016
Q1
$19M Buy
305,400
+15,028
+5% +$936K 0.04% 688
2015
Q4
$17.9M Buy
290,372
+28,172
+11% +$1.83M 0.04% 616
2015
Q3
$16M Buy
262,200
+8,723
+3% +$546K 0.04% 624
2015
Q2
$16.5M Buy
253,477
+8,254
+3% +$524K 0.04% 656
2015
Q1
$15.6M Buy
245,223
+7,623
+3% +$484K 0.03% 709
2014
Q4
$14.9M Sell
237,600
-3,149
-1% -$189K 0.04% 652
2014
Q3
$13.4M Buy
240,749
+1,749
+0.7% +$98.8K 0.04% 612
2014
Q2
$13.5M Sell
239,000
-200
-0.1% -$10.9K 0.03% 676
2014
Q1
$13.3M Buy
239,200
+3,700
+2% +$194K 0.03% 702
2013
Q4
$12.7M Buy
235,500
+2,700
+1% +$138K 0.03% 678
2013
Q3
$11M Buy
232,800
+4,300
+2% +$206K 0.03% 751
2013
Q2
$10.9M Buy
+228,500
New +$10.7M 0.03% 687

Other funds holding NHC

Renaissance Technologies's NHC Position: Q1 2026 in Review

Renaissance Technologies reduced its National Healthcare (NHC) stake by 4.2% in Q1 2026, selling an estimated $2.24M and leaving 335,517 shares worth $53.6M. The position accounts for 0.08% of the portfolio, ranked #303.

Renaissance Technologies first reported a position in NHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.7M in Q4 2019. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Renaissance Technologies held 335,517 shares of National Healthcare worth $53.6M as of Q1 2026.
  • Renaissance Technologies sold 14,600 National Healthcare shares in Q1 2026, an estimated $2.24M.
  • National Healthcare made up 0.08% of Renaissance Technologies's portfolio in Q1 2026, its #303 holding.
  • Renaissance Technologies first reported a position in National Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Renaissance Technologies's National Healthcare position peaked at $57.7M in Q4 2019.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.